Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 24 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07129252
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +13 more
- Locations
-
- Crinetics Study Site Phoenix, Arizona, United States
- Crinetics Study Site Duarte, California, United States
- Crinetics Study Site Newport Beach, California, United States
- Crinetics Study Site Orange, California, United States
NCT02402244
- Conditions
- Adrenal Gland Pheochromocytoma, Bone Marrow Diseases, Carcinoma, +59 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
NCT06732505
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China
NCT04464122
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
- Locations
-
- Andrea M Isidori Rome, Italy
Recruiting
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
NCT05165407
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Bejing cancer hospital Beijing, Beijing Municipality, China
NCT06855095
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
- Locations
-
- Antoni van Leeuwenhoek Amsterdam, Netherlands
Recruiting
EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms
NCT06785597
- Conditions
- Mixed Neuroendocrine-Non Neuroendocrine Neoplasm, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- European Institute of Oncology Milan, Italy
NCT04917484
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Aarhus University Hospital, department of Nuclear medicine and PET centre Aarhus, Palle Juul-Jensens Boulevard, Denmark
NCT06276309
- Conditions
- Cervical Cancer, Cervical Lesion, China, +20 more
- Locations
-
- Fujian Maternity and Child Health Hospital Fuzhou, Fujian, China
- Fujian Provincial Hospital Fuzhou, Fujian, China
- Ningde Mindong Hospital Ningde, Fujian, China
- Putian City first Hospital Putian, Fujian, China
NCT06523582
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Adenoma, +103 more
- Locations
-
- Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social Mexico City, Mexico
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico
- Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México Mexico City, Mexico
NCT06337760
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- European Institute of Oncology Milan, Italy
Not Yet Recruiting
Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms
NCT07684170
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +9 more
- Locations
-
Not specified
NCT02402920
- Conditions
- Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neoplasms, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01638533
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT03980925
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +6 more
- Locations
-
- Institut Català d'Oncologia Badalona Badalona, Barcelona, Spain
- Institut Català d'Oncologia l'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
- Vall d'Hebron University Hospital Barcelona, Spain
- Hospital Universitario 12 de Octubre Madrid, Spain
NCT02399215
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
NCT05879055
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
- Fujian Province Cancer Hospital Fuzhou, Fujian, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Active, Not Recruiting
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT07118176
- Conditions
- Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +127 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
NCT03375320
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
- Locations
-
- Katmai Oncology Group Anchorage, Alaska, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors
NCT04750954
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States